The firm has also announced key hires, including Glen Dyer as Design Director and Alice Inigo-Jones as Development & Strategy ...

Promethean, a leading global education technology company and brand owned by Mynd.ai, Inc. , won this year's Tech & Learning Awards of Excellence: Back to School 2024 in the Primary category from Tech ...

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...

A Merck & Co. Inc. diverse leadership program unlawfully excludes White and Asian workers, according to an EEOC charge filed ...

The antibody drug conjugate didn’t help patients live longer in a confirmatory trial, prompting a review of its conditional ...

Merck's recent decline is due to reduced profit guidance and FDA decisions, but shares are at a support level that is likely to hold. Keytruda remains a key revenue driver, with potential for ...

In a report released on October 4, Carter Gould from Barclays maintained a Buy rating on Merck & Company (MRK – Research Report), with a price target of $140.00. The company’s shares closed ...

(RTTNews) - Drug makers Exelixis, Inc. (EXEL) and Merck & Co Inc.(MRK) announced Monday that they have entered into a clinical development collaboration to evaluate the combination of Exelixis ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

EXEL is set to evaluate investigational zanzalintinib in combination with Merck;s Keytruda (pembrolizumab) and Welireg in head and neck cancer and renal cell carcinoma, respectively. ALAMEDA ...